Metlife Inc. buy UBS Group AG
Summary
This prediction is currently active. The prediction for Metlife Inc. disappoints with a performance of -13.52%. This prediction currently runs until 02.04.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Metlife Inc. | -4.867% | -4.867% |
| iShares Core DAX® | 0.683% | 0.785% |
| iShares Nasdaq 100 | -1.457% | 3.734% |
| iShares Nikkei 225® | 0.931% | 2.958% |
| iShares S&P 500 | -2.022% | 2.444% |
Comments by UBS_Group_AG for this prediction
In the thread Metlife Inc. diskutieren